221 related articles for article (PubMed ID: 23036831)
1. Craniofacial development: current concepts in the molecular basis of Treacher Collins syndrome.
van Gijn DR; Tucker AS; Cobourne MT
Br J Oral Maxillofac Surg; 2013 Jul; 51(5):384-8. PubMed ID: 23036831
[TBL] [Abstract][Full Text] [Related]
2. Tissue specific roles for the ribosome biogenesis factor Wdr43 in zebrafish development.
Zhao C; Andreeva V; Gibert Y; LaBonty M; Lattanzi V; Prabhudesai S; Zhou Y; Zon L; McCann KL; Baserga S; Yelick PC
PLoS Genet; 2014 Jan; 10(1):e1004074. PubMed ID: 24497835
[TBL] [Abstract][Full Text] [Related]
3. Treacher Collins syndrome.
Dixon J; Trainor P; Dixon MJ
Orthod Craniofac Res; 2007 May; 10(2):88-95. PubMed ID: 17552945
[TBL] [Abstract][Full Text] [Related]
4. The Roles of RNA Polymerase I and III Subunits Polr1c and Polr1d in Craniofacial Development and in Zebrafish Models of Treacher Collins Syndrome.
Noack Watt KE; Achilleos A; Neben CL; Merrill AE; Trainor PA
PLoS Genet; 2016 Jul; 12(7):e1006187. PubMed ID: 27448281
[TBL] [Abstract][Full Text] [Related]
5. Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders.
Calo E; Gu B; Bowen ME; Aryan F; Zalc A; Liang J; Flynn RA; Swigut T; Chang HY; Attardi LD; Wysocka J
Nature; 2018 Feb; 554(7690):112-117. PubMed ID: 29364875
[TBL] [Abstract][Full Text] [Related]
6. Re: Craniofacial development: current concepts in the molecular basis of Treacher Collins syndrome.
Green B; Nikkhah D; Cobb AR; Dunaway DJ
Br J Oral Maxillofac Surg; 2013 Apr; 51(3):276. PubMed ID: 23273823
[No Abstract] [Full Text] [Related]
7. The Treacher Collins syndrome (TCOF1) gene product is involved in pre-rRNA methylation.
Gonzales B; Henning D; So RB; Dixon J; Dixon MJ; Valdez BC
Hum Mol Genet; 2005 Jul; 14(14):2035-43. PubMed ID: 15930015
[TBL] [Abstract][Full Text] [Related]
8. Treacher Collins Syndrome: the genetics of a craniofacial disease.
Kadakia S; Helman SN; Badhey AK; Saman M; Ducic Y
Int J Pediatr Otorhinolaryngol; 2014 Jun; 78(6):893-8. PubMed ID: 24690222
[TBL] [Abstract][Full Text] [Related]
9. Genetic background has a major effect on the penetrance and severity of craniofacial defects in mice heterozygous for the gene encoding the nucleolar protein Treacle.
Dixon J; Dixon MJ
Dev Dyn; 2004 Apr; 229(4):907-14. PubMed ID: 15042714
[TBL] [Abstract][Full Text] [Related]
10. [Pathogenic genes and clinical therapeutic strategies for Treacher Collins syndrome].
Yin B; Shi B; Jia ZL
Hua Xi Kou Qiang Yi Xue Za Zhi; 2019 Jun; 37(3):330-335. PubMed ID: 31218872
[TBL] [Abstract][Full Text] [Related]
11. Treacher Collins syndrome: unmasking the role of Tcof1/treacle.
Sakai D; Trainor PA
Int J Biochem Cell Biol; 2009 Jun; 41(6):1229-32. PubMed ID: 19027870
[TBL] [Abstract][Full Text] [Related]
12. Another face of the Treacher Collins syndrome (TCOF1) gene: identification of additional exons.
So RB; Gonzales B; Henning D; Dixon J; Dixon MJ; Valdez BC
Gene; 2004 Mar; 328():49-57. PubMed ID: 15019983
[TBL] [Abstract][Full Text] [Related]
13. The Role of
Grzanka M; Piekiełko-Witkowska A
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33804586
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of apoptosis in the prefusion neural folds underlie the craniofacial disorder, Treacher Collins syndrome.
Dixon J; Brakebusch C; Fässler R; Dixon MJ
Hum Mol Genet; 2000 Jun; 9(10):1473-80. PubMed ID: 10888597
[TBL] [Abstract][Full Text] [Related]
15. POLR1B and neural crest cell anomalies in Treacher Collins syndrome type 4.
Sanchez E; Laplace-Builhé B; Mau-Them FT; Richard E; Goldenberg A; Toler TL; Guignard T; Gatinois V; Vincent M; Blanchet C; Boland A; Bihoreau MT; Deleuze JF; Olaso R; Nephi W; Lüdecke HJ; Verheij JBGM; Moreau-Lenoir F; Denoyelle F; Rivière JB; Laplanche JL; Willing M; Captier G; Apparailly F; Wieczorek D; Collet C; Djouad F; Geneviève D
Genet Med; 2020 Mar; 22(3):547-556. PubMed ID: 31649276
[TBL] [Abstract][Full Text] [Related]
16. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function.
Jones NC; Lynn ML; Gaudenz K; Sakai D; Aoto K; Rey JP; Glynn EF; Ellington L; Du C; Dixon J; Dixon MJ; Trainor PA
Nat Med; 2008 Feb; 14(2):125-33. PubMed ID: 18246078
[TBL] [Abstract][Full Text] [Related]
17. Clinical features, treatment and genetic background of Treacher Collins syndrome.
Marszałek B; Wójcicki P; Kobus K; Trzeciak WH
J Appl Genet; 2002; 43(2):223-33. PubMed ID: 12080178
[TBL] [Abstract][Full Text] [Related]
18. Treacher Collins syndrome with a de Novo 5-bp deletion in the TCOF1 gene.
Su PH; Chen JY; Chen SJ; Yu JS
J Formos Med Assoc; 2006 Jun; 105(6):518-21. PubMed ID: 16801042
[TBL] [Abstract][Full Text] [Related]
19. Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities.
Dixon J; Jones NC; Sandell LL; Jayasinghe SM; Crane J; Rey JP; Dixon MJ; Trainor PA
Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13403-8. PubMed ID: 16938878
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the nucleolar gene product, treacle, in Treacher Collins syndrome.
Isaac C; Marsh KL; Paznekas WA; Dixon J; Dixon MJ; Jabs EW; Meier UT
Mol Biol Cell; 2000 Sep; 11(9):3061-71. PubMed ID: 10982400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
